coronavirus

NEW -> Contingent Buyer Assistance Program
I think I'm not getting another shot after this 3rd one.
If I get omicron, it'll be like my 4th shot.
 
Reasonable...I thought 55 years was way too short...

FDA Claims It Needs Until 2096 to Fully Release Pfizer COVID-19 Vaccine Data

The United States Food and Drug Administration (FDA) is saying that it needs a full 75 years in order to fully release all data concerning the Pfizer and BioNTech vaccine against COVID-19. Previously, the FDA claimed it needed 55 years to release vaccine information such as safety, efficacy, test protocols, and adverse reaction reports, among other data.

The release of the vaccine data was prompted by a Freedom of Information Act (FOIA) request brought by the group Public Health and Medical Professionals for Transparency (PHMPT). The group claims that the information should be available quickly since the FDA spent only 108 days reviewing the same data prior to granting an emergency use authorization for the vaccine.
https://thenewamerican.com/fda-clai...o-fully-release-pfizer-covid-19-vaccine-data/
 
Is this common practice for all vaccines? Please add more context.

morekaos said:
Reasonable...I thought 55 years was way too short...

FDA Claims It Needs Until 2096 to Fully Release Pfizer COVID-19 Vaccine Data

The United States Food and Drug Administration (FDA) is saying that it needs a full 75 years in order to fully release all data concerning the Pfizer and BioNTech vaccine against COVID-19. Previously, the FDA claimed it needed 55 years to release vaccine information such as safety, efficacy, test protocols, and adverse reaction reports, among other data.

The release of the vaccine data was prompted by a Freedom of Information Act (FOIA) request brought by the group Public Health and Medical Professionals for Transparency (PHMPT). The group claims that the information should be available quickly since the FDA spent only 108 days reviewing the same data prior to granting an emergency use authorization for the vaccine.
https://thenewamerican.com/fda-clai...o-fully-release-pfizer-covid-19-vaccine-data/
Click to expand...
 
unvaxxed-sperm-cryptocurrency-bitcoin.jpg
 
More misinformation from those white supremacists morons at CDC/Reuter:

Most reported US Omnicron casse have hit fully vaccinated
And a third of them have boosters. Time to quadruple jab and wear quadruple masks, people.
Also no wonder you will start to see the language vaccine schedule rather than vaccinated. By adding schedule it means this jab requirement will never end.

I guess Calbears is not fully vaccinated because he does not have 4th shot yet.
https://www.reuters.com/world/us/mo...ses-have-hit-fully-vaccinated-cdc-2021-12-10/
 
The U.S. Centers for Disease Control and Prevention (CDC) said that of the 43 cases attributed to Omicron variant, 34 people had been fully vaccinated. Fourteen of them had also received a booster, although five of those cases occurred less than 14 days after the additional shot before full protection kicks in.
<snip>

Among the Omicron cases, 25 were in people aged 18 to 39 and 14 had traveled internationally. Six people had previously been infected with the coronavirus.
Click to expand...

We need a few zero after those numbers, right now the data is highly skewed by the Anime convention.

By Christmas we should have a good feel if it just blows through everything and by New Years we should get a feel for how many are going to the hospital.

Britain reported an Omicron death today, but no other stats on it other than they have ten in the hospitals with Omicron confirmed ages 18-85.
 
California mask mandate this Wednesday because of Omnicron. I guess Omnicron doesn't work on Monday and Tuesday. Oh and vaccinated needs to comply as well. I think it is better to call people with 3 to 1 shots partially vaccinated. You need the 4th shot for Omnicron to be temporarily fully vaccinated until the next variant.
 
CDC weighs changes to J&J vaccine authorization.  Good news in that the systems are working.  Bad news in that is some nasty rate for Women 30-49.

Vaccine advisers to the Centers for Disease Control and Prevention are meeting Thursday to weigh possible limits on the use of the Johnson & Johnson vaccine because of continued blood clot issues, mostly in young and middle-aged women, according to clinicians familiar with the agenda.?The single-dose vaccine has been linked to a rare and severe type of blood clot, which halted its use for 10 days in April as federal health officials looked more closely at six women who experienced the problem ? the only known cases among more than 7 million people who received the vaccine in the United States at that time. One of the women died. The pause was lifted after an extensive safety review that determined the vaccine?s benefits outweighed the risks.?On Thursday, the Advisory Committee on Immunization Practices will be presented with new data that appears to show the rate of the clots in people who received the Johnson & Johnson shot has increased since April, although the problem is still rare. There have been about nine deaths related to the issue, according to a federal official familiar with the situation.?The FDA, in an update to its fact sheet on the vaccine this week, said the highest reporting rate of clot issues ? about one case per 100,000 doses administered ? has been in women 30 to 49 years old.?A comprehensive review of the blood clot condition following vaccinations between last December and Aug. 31 found six deaths among 50 confirmed cases of the blood clot condition among recipients of the one-shot regimen. During that period, 14 million doses of the vaccine were given, according to the study published last month, which has not yet been peer-reviewed.
Click to expand...
https://www.washingtonpost.com/health/2021/12/15/johnson-and-johnson-vaccine-continued-blood-clots/
 
White supremacists morons have infiltrated CDC and Washington Post

nosuchreality said:
CDC weighs changes to J&J vaccine authorization.  Good news in that the systems are working.  Bad news in that is some nasty rate for Women 30-49.

Vaccine advisers to the Centers for Disease Control and Prevention are meeting Thursday to weigh possible limits on the use of the Johnson & Johnson vaccine because of continued blood clot issues, mostly in young and middle-aged women, according to clinicians familiar with the agenda.?The single-dose vaccine has been linked to a rare and severe type of blood clot, which halted its use for 10 days in April as federal health officials looked more closely at six women who experienced the problem ? the only known cases among more than 7 million people who received the vaccine in the United States at that time. One of the women died. The pause was lifted after an extensive safety review that determined the vaccine?s benefits outweighed the risks.?On Thursday, the Advisory Committee on Immunization Practices will be presented with new data that appears to show the rate of the clots in people who received the Johnson & Johnson shot has increased since April, although the problem is still rare. There have been about nine deaths related to the issue, according to a federal official familiar with the situation.?The FDA, in an update to its fact sheet on the vaccine this week, said the highest reporting rate of clot issues ? about one case per 100,000 doses administered ? has been in women 30 to 49 years old.?A comprehensive review of the blood clot condition following vaccinations between last December and Aug. 31 found six deaths among 50 confirmed cases of the blood clot condition among recipients of the one-shot regimen. During that period, 14 million doses of the vaccine were given, according to the study published last month, which has not yet been peer-reviewed.
Click to expand...
https://www.washingtonpost.com/health/2021/12/15/johnson-and-johnson-vaccine-continued-blood-clots/
Click to expand...
 
Well, best hope Omi is essentially a cold.

Regeneron Pharmaceuticals, the maker of a popular monoclonal antibody cocktail used as a treatment for many coronavirus patients who have not been vaccinated, announced Thursday that its covid-19 therapy loses potency against the omicron variant.?

The company, which warned earlier this month that its antibody treatment may not be as effective against the new variant, said data confirms it has ?diminished potency? against omicron but remains useful against delta.??While Regeneron?s currently authorized REGEN-COV antibodies have diminished potency against Omicron, they are active against Delta, which currently is the most prevalent variant in the U.S.,? the company said in a news release.
https://www.washingtonpost.com/health/2021/12/16/regeneron-omicron-diminished-potency-covid/
https://investor.regeneron.com/static-files/4aed42a1-3d26-48af-bd01-3f0c92938c11
Click to expand...
 
https://statements.cornell.edu/2021/20211214-LTBmB1-ithaca-alert.cfm

<snip>

While I want to provide reassurance that, to date, we have not seen severe illness in any of our infected students, we do have a role to play in reducing the spread of the disease in the broader community. The fact that we have not experienced severe illness among our student population may lead some to ask why we are imposing such serious steps. So let me share the underlying math: Consider one variant, let?s call it A, in which each person infects two others on average, and which causes serious illness in 1% of cases. After ten iterations of transmission, you?ll have about 1,000 cases, and 10 instances of serious illness. Now consider variant B, which is twice as infectious, so each person infects four others on average, but which causes serious illness only one-tenth as often, i.e., in only 0.1% of cases. Unchecked, over the same ten iterations of transmission, with variant B you?ll have more than a million cases, and about 1,000 individuals with serious illness. Of course, other factors come into play, including the fact that the virus will ?run out? of people to infect in any community, but the point is that higher transmissibility leads to exponential growth, which outweighs the linear decrease in percent of severe cases. To avoid this type of situation, it is imperative not to let such infections run unchecked, but to take steps that limit transmission.

<snip>
Click to expand...

 
Purdue has both mask and vaccine mandate. So this means current  mask and vaccine protocol doesn't really prevent transmission and  infection.

So the mask mandate needs to be updated to wearing triple mask. The vaccinate mandate needs to include participating in early clinical trial of the upcoming 4th, 5th, ...etc booster shots from Pfizer. 


nosuchreality said:
https://statements.cornell.edu/2021/20211214-LTBmB1-ithaca-alert.cfm

<snip>

While I want to provide reassurance that, to date, we have not seen severe illness in any of our infected students, we do have a role to play in reducing the spread of the disease in the broader community. The fact that we have not experienced severe illness among our student population may lead some to ask why we are imposing such serious steps. So let me share the underlying math: Consider one variant, let?s call it A, in which each person infects two others on average, and which causes serious illness in 1% of cases. After ten iterations of transmission, you?ll have about 1,000 cases, and 10 instances of serious illness. Now consider variant B, which is twice as infectious, so each person infects four others on average, but which causes serious illness only one-tenth as often, i.e., in only 0.1% of cases. Unchecked, over the same ten iterations of transmission, with variant B you?ll have more than a million cases, and about 1,000 individuals with serious illness. Of course, other factors come into play, including the fact that the virus will ?run out? of people to infect in any community, but the point is that higher transmissibility leads to exponential growth, which outweighs the linear decrease in percent of severe cases. To avoid this type of situation, it is imperative not to let such infections run unchecked, but to take steps that limit transmission.

<snip>
Click to expand...
Click to expand...
 
@akula:

You keep bashing mask wearing without any significant proof.

It's not going to be 100% preventative but it does help reduce the viral load in enclosed spaces. That's not theory... that's just science and actually... common sense.
 
You do know that wearing mask long term is not healthy, depriving human body of needed oxygen? SiO2 drops if wearing mask long term.
You also know that mask can trap geRms and if not wearing properly, it doesn't do much?

In theory it can help for large droplets, but there are so many other factors at the end the net benefits is muted, become nothing more than virtue signaling
 
akula1488 said:
You do know that wearing mask long term is not healthy, depriving human body of needed oxygen? SiO2 drops if wearing mask long term.
You also know that mask can trap geRms and if not wearing properly, it doesn't do much?

In theory it can help for large droplets, but there are so many other factors at the end the net benefits is muted, become nothing more than virtue signaling
Click to expand...

smh

Who believes this? sheeeesh
Is this Mety?s alt account. smh
 
eyephone said:
akula1488 said:
You do know that wearing mask long term is not healthy, depriving human body of needed oxygen? SiO2 drops if wearing mask long term.
You also know that mask can trap geRms and if not wearing properly, it doesn't do much?

In theory it can help for large droplets, but there are so many other factors at the end the net benefits is muted, become nothing more than virtue signaling
Click to expand...

smh

Who believes this? sheeeesh
Is this Mety?s alt account. smh
Click to expand...

A "moderate" Trumper with "critical thinking" would believe that.  ;D
 
You must log in or register to reply here.
Back
Top